122
Views
48
CrossRef citations to date
0
Altmetric
Original Research

A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations

, , , , , , , & show all
Pages 259-271 | Published online: 31 May 2013

References

  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease2013 Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdfAccessed January 2013
  • SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1998157141814229603117
  • MiravitllesMGuerreroTMayordomoCSanchez-AgudoLNicolauFSeguJLFactors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study GroupRespiration20006749550111070451
  • NiewoehnerDELokhnyginaYRiceKRisk indexes for exacerbations and hospitalizations due to COPDChest2007131202817218552
  • CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med20043501005101214999112
  • PuhanMAGarcia-AymerichJFreyMExpansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO indexLancet200937470471119716962
  • JonesRCDonaldsonGCChavannesNHDerivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE IndexAm J Respir Crit Care Med20091801189119519797160
  • RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med200717653255517507545
  • No authors listedStandardization of Spirometry, 1994 Update. American Thoracic SocietyAm J Respir Crit Care Med1995152110711367663792
  • Japanese Respiratory SocietyThe predicted values of spirometry and arterial blood gas analysis in JapaneseJ Jap Resp Soc200139 Appendix (In Japanese)
  • MahlerDAWellsCKEvaluation of clinical methods for rating dyspneaChest1988935805863342669
  • ATS Committee on Proficiency Standards for Clinical Pulmonary Function LaboratoriesATS statement: guidelines for the six-minute walk testAm J Respir Crit Care Med200216611111712091180
  • CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis1987403733833558716
  • HosmerDWLemeshowSApplied Logistic Regression2nd edHoboken, NJ, USAJohn Wiley & Sons2000
  • HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med20103631128113820843247
  • SundhJJansonCLisspersKStallbergBMontgomerySThe Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPDPrim Care Respir J20122129530122786813
  • ChavannesNHJonesRCPostmaDSRennardSUsing COPD multidimensional indices in routine clinical practice: DOSE meets all criteriaPrim Care Respir J20122124524622836739
  • FaganelloMMTanniSESanchezFFPelegrinoNRLuchetaPAGodoyIBODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary diseaseAm J Med Sci2010339101419926966
  • MarinJMCarrizoSJCasanovaCPrediction of risk of COPD exacerbations by the BODE indexRespir Med200910337337819013781
  • WHO Expert ConsultationAppropriate body-mass index for Asian populations and its implications for policy and intervention strategiesLancet200436315716314726171
  • DonaldsonGCSeemungalTAPatelISLloyd-OwenSJWilkinsonTMWedzichaJALongitudinal changes in the nature, severity and frequency of COPD exacerbationsEur Respir J20032293193614680081
  • QuintJKDonaldsonGCHurstJRGoldringJJSeemungalTRWedzichaJAPredictive accuracy of patient-reported exacerbation frequency in COPDEur Respir J20113750150720650988
  • EffingTWKerstjensHAMonninkhofEMDefinitions of exacerbations: does it really matter in clinical trials on COPD?Chest200913691892319736196
  • WaltersEHWaltersJWillsKERobinsonAWood-BakerRClinical diaries in COPD: compliance and utility in predicting acute exacerbationsInt J Chron Obstruct Pulmon Dis2012742743522848156
  • BischoffEWBoerLMMolemaJValidity of an automated telephonic system to assess COPD exacerbation ratesEur Respir J2012391090109621920893
  • CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med200735677578917314337
  • TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
  • NishimuraMMakitaHNagaiKAnnual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012185445222016444
  • FukuchiYFernandezLKuoHPEfficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trialRespirology20111682583521539680
  • IkegamiNYooBKHashimotoHJapanese universal health coverage: evolution, achievements, and challengesLancet20113781106111521885107
  • WakabayashiRMotegiTYamadaKIshiiTGemmaAKidaKPresence of in-home caregiver and health outcomes of older adults with chronic obstructive pulmonary diseaseJ Am Geriatr Soc201159444921198462
  • EisnerMDBlancPDOmachiTASocioeconomic status, race and COPD health outcomesJ Epidemiol Community Health201165263419854747
  • HanMKCurran-EverettDDransfieldMTRacial differences in quality of life in patients with COPDChest20111401169117621636665
  • LangsetmoLPlattRWErnstPBourbeauJUnderreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohortAm J Respir Crit Care Med200817739640118048806
  • BurgelPRNesme-MeyerPChanezPCough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjectsChest200913597598219017866
  • TeradaKMuroSSatoSImpact of gastro-oesophageal reflux disease symptoms on COPD exacerbationThorax20086395195518535116